Fragile histidine triad (FHIT) gene abnormalities in lung cancer

Clinical Lung Cancer

Volumn 2, Issue 2, 2000, Pages 141-145

  Zöchbauer Müller, Sabine ^a,b   Wistuba, Ignacio I ^a   Minna, John D ^a,b   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chromosome 3p; FHIT; FRA3B; Lung cancer; Tumor suppressor gene

Indexed keywords

CARCINOGEN; TOBACCO SMOKE;

ALLELE; ARTICLE; BRONCHUS BIOPSY; CAUSE OF DEATH; CHROMOSOME 3P; CIGARETTE SMOKING; CYTOLOGY; EXON; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE LOCATION; GENE LOCUS; GENE LOSS; GENE MUTATION; GENETIC TRANSCRIPTION; GENOME; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MOLECULAR BIOLOGY; PATHOGENESIS; THEORY; TUMOR SUPPRESSOR GENE;

EID: 0034463753     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2000.n.027     Document Type: Article

References (43)

1. Global cancer statistics
2. Cancer statistics, 2000
3. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
4. Progress in understanding the molecular pathogenesis of human lung cancer
5. Hereditary cancers disclose a class of cancer genes
6. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
7. Three distinct regions involved in 3p deletion in human lung cancer
8. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
9. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae
10. Mutation of a mutL homolog in hereditary colon cancer
11. Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene
12. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: Progress toward the isolation of a lung cancer TSG
13. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin
14. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns
15. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer
16. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
17. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
18. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations
19. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer
20. Clonal genetic alterations in the lungs of current and former smokers
21. Molecular damage in the bronchial epithelium of current and former smokers
22. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B
23. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines
24. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes
25. Hereditary renal-cell carcinoma associated with a chromosomal translocation
26. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
27. The FHIT gene '3p14.2 is abnormal in lung cancer
28. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands
29. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines
30. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas
31. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas
32. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue
33. Protein expression and functional analysis of the FHIT gene in human tumor cells
34. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma
35. Loss of FHIT function in lung cancer and preinvasive bronchial lesions
36. Loss of Fhit expression in non-small-cell lung cancer: Correlation with molecular genetic abnormalities and clinicopathological features
37. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers
38. Chromosome 3p14 alterations in lung cancer: Evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos
39. Replacement of Fhit in cancer cells suppresses tumorigenicity
40. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene over-expression
41. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control
42. Role of FHIT in human cancer
43. An FHIT tumor suppressor gene?